Govt Mulls Rule To Force Pharmacies To Dispense Exact Prescription Quantities: Chemist Body Resists

Govt Mulls Rule To Force Pharmacies To Dispense Exact Prescription Quantities: Chemist Body Resists

Last Updated:April 10, 2026, 06:30 IST AIOCD writes to DCGI, citing drug safety risks, financial losses; warns policy rolled out without stakeholder consultation The outcome will be closely watched by both patient advocacy groups—who have long complained about being forced to over-purchase medicines—and the pharmacy trade, which argues it is being asked to absorb costs without any…

Read More
WHO Issues Global Alert Over Contaminated Indian Cough Syrups

WHO Issues Global Alert Over Contaminated Indian Cough Syrups

Last Updated:October 15, 2025, 04:01 IST The WHO has called for vigilance across all countries, especially concerning informal and unregulated supply chains, where these products could still circulate undetected The affected products are Coldrif (from Sresan Pharmaceutical), Respifresh TR (from Rednex Pharmaceuticals), and ReLife (from Shape Pharma). Representational image/X The World Health Organization (WHO) has…

Read More
India Confirmed Toxic DEG In 3 Syrups Linked To Child Deaths, WHO Tells News18: ‘Deeply Concerned’

India Confirmed Toxic DEG In 3 Syrups Linked To Child Deaths, WHO Tells News18: ‘Deeply Concerned’

Last Updated:October 08, 2025, 11:45 PM IST WHO had earlier told News18 that it had contacted the CDSCO for clarification regarding the incidents but had not received a reply In the updated response, the WHO said that the Indian regulatory agency, CDSCO, has clarified that ‘none of the products’ were exported from India. (File photo)…

Read More
MSME Ministry Flags ‘Medicine Crisis’ To Drug Regulator & Pharma Dept After PMO Nudge

MSME Ministry Flags ‘Medicine Crisis’ To Drug Regulator & Pharma Dept After PMO Nudge

Last Updated:September 21, 2025, 00:39 is The Federation of Pharma Entrepreneurs (FOPE) warns that many MSMEs face closure due to costly GMP upgrades Central to FOPE’s demand is an extension of the compliance deadline for the revised Schedule M. Representational image The Ministry of Micro, Small and Medium Enterprises (MSME) has asked the Department of…

Read More
Eye Drop Preparations, Other Drugs May Soon Carry Braille Labels Or Voice-Enabled QR Codes

Eye Drop Preparations, Other Drugs May Soon Carry Braille Labels Or Voice-Enabled QR Codes

Last Updated:September 10, 2025, 07:00 is The CDSCO has invited public comments on the proposal, marking a significant step towards improving accessibility for the visually impaired population To support easier access to medication for visually impaired persons, the guideline on additional labelling in Braille is proposed to be implemented ‘initially voluntarily’ for drugs supplied in…

Read More
Ask Antacid Ranitidine Makers To Monitor Chances Of Cancer-Causing Impurity: Drug Controller To States

Ask Antacid Ranitidine Makers To Monitor Chances Of Cancer-Causing Impurity: Drug Controller To States

Last Updated:July 27, 2025, 07:00 is NDMA presence in the acid-reflux drug under scrutiny again; states told to ensure manufacturers take risk-based safety steps Ranitidine is a medication that lowers stomach acid production and helps relieve acid-related indigestion and heartburn. It is commonly available under brand names like Aciloc, Rantac, and Zinetac. (Representational pic/Reuters) In…

Read More
Bombay High Court Initiates Suo Motu PIL Over Drug Sales To Students, Appoints Amicus Curiae

Bombay High Court Initiates Suo Motu PIL Over Drug Sales To Students, Appoints Amicus Curiae

Last Updated:June 26, 2025, 03:43 is The court said that the consumption of such substances by students of an impressionable age was leading them down a destructive path of addiction News reports alleged that a network of law offenders was operating openly in Chhatrapati Sambhajinagar, selling drugs, cigarettes, and e-cigarettes to school and college students….

Read More
Centre Plans To Restrict New TB Drugs To Govt Channels, Bar Private Sale

Centre Plans To Restrict New TB Drugs To Govt Channels, Bar Private Sale

Last Updated:June 26, 2025, 00:53 is Experts fear that unregulated access could lead to indiscriminate use, risking treatment failures and accelerating the development of drug resistance According to WHO’s Global TB Report, India has made significant progress in fighting tuberculosis. Under the NTEP, the incidence rate of TB cases has dropped by nearly 17.7%, from…

Read More